{"title":"肠道细菌衍生的膜囊泡通过诱导结肠上皮细胞 DNA 损伤而诱发结肠发育不良","authors":"Yu Miyakawa , Motoyuki Otsuka , Chikako Shibata , Takahiro Seimiya , Keisuke Yamamoto , Rei Ishibashi , Takahiro Kishikawa , Eri Tanaka , Takayuki Isagawa , Norihiko Takeda , Noriaki Kamio , Kenichi Imai , Mitsuhiro Fujishiro","doi":"10.1016/j.jcmgh.2024.01.010","DOIUrl":null,"url":null,"abstract":"<div><h3>Background & Aims</h3><p>Colorectal cancer (CRC) is the third most common cancer in the world. Gut microbiota has recently been implicated in the development of CRC. <em>Actinomyces odontolyticus</em> is one of the most abundant bacteria in the gut of patients with very early stages of CRC. <em>A odontolyticus</em> is an anaerobic bacterium existing principally in the oral cavity, similar to <em>Fusobacterium nucleatum,</em> which is known as a colon carcinogenic bacterium. Here we newly determined the biological functions of <em>A odontolyticus</em> on colonic oncogenesis.</p></div><div><h3>Methods</h3><p>We examined the induction of intracellular signaling by <em>A odontolyticus</em> in human colonic epithelial cells (CECs). DNA damage levels in CECs were confirmed using the human induced pluripotent stem cell-derived gut organoid model and mouse colon tissues in vivo.</p></div><div><h3>Results</h3><p><em>A odontolyticus</em> secretes membrane vesicles (MVs), which induce nuclear factor kappa B signaling and also produce excessive reactive oxygen species (ROS) in colon epithelial cells. We found that <em>A odontolyticus</em> secretes lipoteichoic acid-rich MVs, promoting inflammatory signaling via TLR2. Simultaneously, those MVs are internalized into the colon epithelial cells, co-localize with the mitochondria, and cause mitochondrial dysfunction, resulting in excessive ROS production and DNA damage. Induction of excessive DNA damage in colonic cells by <em>A odontolyticus</em>-derived MVs was confirmed in the gut organoid model and also in mouse colon tissues.</p></div><div><h3>Conclusions</h3><p><em>A odontolyticus</em> secretes MVs, which cause chronic inflammation and ROS production in colonic epithelial cells, leading to the initiation of CRC.</p></div>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":"17 5","pages":"Pages 745-767"},"PeriodicalIF":7.1000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2352345X24000109/pdfft?md5=e23ca47bd954111738ee31e9c0a144d5&pid=1-s2.0-S2352345X24000109-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Gut Bacteria-derived Membrane Vesicles Induce Colonic Dysplasia by Inducing DNA Damage in Colon Epithelial Cells\",\"authors\":\"Yu Miyakawa , Motoyuki Otsuka , Chikako Shibata , Takahiro Seimiya , Keisuke Yamamoto , Rei Ishibashi , Takahiro Kishikawa , Eri Tanaka , Takayuki Isagawa , Norihiko Takeda , Noriaki Kamio , Kenichi Imai , Mitsuhiro Fujishiro\",\"doi\":\"10.1016/j.jcmgh.2024.01.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background & Aims</h3><p>Colorectal cancer (CRC) is the third most common cancer in the world. Gut microbiota has recently been implicated in the development of CRC. <em>Actinomyces odontolyticus</em> is one of the most abundant bacteria in the gut of patients with very early stages of CRC. <em>A odontolyticus</em> is an anaerobic bacterium existing principally in the oral cavity, similar to <em>Fusobacterium nucleatum,</em> which is known as a colon carcinogenic bacterium. Here we newly determined the biological functions of <em>A odontolyticus</em> on colonic oncogenesis.</p></div><div><h3>Methods</h3><p>We examined the induction of intracellular signaling by <em>A odontolyticus</em> in human colonic epithelial cells (CECs). DNA damage levels in CECs were confirmed using the human induced pluripotent stem cell-derived gut organoid model and mouse colon tissues in vivo.</p></div><div><h3>Results</h3><p><em>A odontolyticus</em> secretes membrane vesicles (MVs), which induce nuclear factor kappa B signaling and also produce excessive reactive oxygen species (ROS) in colon epithelial cells. We found that <em>A odontolyticus</em> secretes lipoteichoic acid-rich MVs, promoting inflammatory signaling via TLR2. Simultaneously, those MVs are internalized into the colon epithelial cells, co-localize with the mitochondria, and cause mitochondrial dysfunction, resulting in excessive ROS production and DNA damage. Induction of excessive DNA damage in colonic cells by <em>A odontolyticus</em>-derived MVs was confirmed in the gut organoid model and also in mouse colon tissues.</p></div><div><h3>Conclusions</h3><p><em>A odontolyticus</em> secretes MVs, which cause chronic inflammation and ROS production in colonic epithelial cells, leading to the initiation of CRC.</p></div>\",\"PeriodicalId\":55974,\"journal\":{\"name\":\"Cellular and Molecular Gastroenterology and Hepatology\",\"volume\":\"17 5\",\"pages\":\"Pages 745-767\"},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2352345X24000109/pdfft?md5=e23ca47bd954111738ee31e9c0a144d5&pid=1-s2.0-S2352345X24000109-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cellular and Molecular Gastroenterology and Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2352345X24000109\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular and Molecular Gastroenterology and Hepatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352345X24000109","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Gut Bacteria-derived Membrane Vesicles Induce Colonic Dysplasia by Inducing DNA Damage in Colon Epithelial Cells
Background & Aims
Colorectal cancer (CRC) is the third most common cancer in the world. Gut microbiota has recently been implicated in the development of CRC. Actinomyces odontolyticus is one of the most abundant bacteria in the gut of patients with very early stages of CRC. A odontolyticus is an anaerobic bacterium existing principally in the oral cavity, similar to Fusobacterium nucleatum, which is known as a colon carcinogenic bacterium. Here we newly determined the biological functions of A odontolyticus on colonic oncogenesis.
Methods
We examined the induction of intracellular signaling by A odontolyticus in human colonic epithelial cells (CECs). DNA damage levels in CECs were confirmed using the human induced pluripotent stem cell-derived gut organoid model and mouse colon tissues in vivo.
Results
A odontolyticus secretes membrane vesicles (MVs), which induce nuclear factor kappa B signaling and also produce excessive reactive oxygen species (ROS) in colon epithelial cells. We found that A odontolyticus secretes lipoteichoic acid-rich MVs, promoting inflammatory signaling via TLR2. Simultaneously, those MVs are internalized into the colon epithelial cells, co-localize with the mitochondria, and cause mitochondrial dysfunction, resulting in excessive ROS production and DNA damage. Induction of excessive DNA damage in colonic cells by A odontolyticus-derived MVs was confirmed in the gut organoid model and also in mouse colon tissues.
Conclusions
A odontolyticus secretes MVs, which cause chronic inflammation and ROS production in colonic epithelial cells, leading to the initiation of CRC.
期刊介绍:
"Cell and Molecular Gastroenterology and Hepatology (CMGH)" is a journal dedicated to advancing the understanding of digestive biology through impactful research that spans the spectrum of normal gastrointestinal, hepatic, and pancreatic functions, as well as their pathologies. The journal's mission is to publish high-quality, hypothesis-driven studies that offer mechanistic novelty and are methodologically robust, covering a wide range of themes in gastroenterology, hepatology, and pancreatology.
CMGH reports on the latest scientific advances in cell biology, immunology, physiology, microbiology, genetics, and neurobiology related to gastrointestinal, hepatobiliary, and pancreatic health and disease. The research published in CMGH is designed to address significant questions in the field, utilizing a variety of experimental approaches, including in vitro models, patient-derived tissues or cells, and animal models. This multifaceted approach enables the journal to contribute to both fundamental discoveries and their translation into clinical applications, ultimately aiming to improve patient care and treatment outcomes in digestive health.